Revolution Medicines (RVMD) Earnings Analysis
Revolution Medicines (RVMD) has no confirmed upcoming earnings date. Last quarter (2025-02-26) it missed with EPS -1.12 USD vs -1.01 USD est (-10.9%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -25.74.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RVMD next report earnings?
No confirmed upcoming earnings date is currently scheduled for RVMD. This page updates as the calendar is published.
RVMD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-02-26 | -1.12 USD | -1.01 USD | -10.9% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
RVMD valuation and analyst view
| Trailing P/E | -25.74 |
|---|---|
| Trailing EPS | -6.92435 USD |
| Price / book | 24.17 |
| Dividend yield | 0.00% |
| Market cap | 38.93B |
| Analyst consensus | Buy (22 buy / 1 hold / 0 sell) |
| Avg price target | 196.16 USD |
Related research pages
Frequently asked questions
When is Revolution Medicines (RVMD)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for RVMD. This page updates as the calendar is published.
Did RVMD beat earnings last quarter?
In its 2025-02-26 report, RVMD posted EPS of -1.12 USD versus a -1.01 USD estimate — a miss of 10.9%.
What is RVMD's earnings track record?
Over the last 1 reported quarters with consensus data, RVMD beat estimates 0 times (0%).
What is RVMD's current P/E ratio and EPS?
RVMD trades at a trailing P/E of -25.74 on trailing EPS of -6.924353979118229 USD.
What do analysts rate RVMD?
Analyst consensus is "Buy" across 23 ratings (1 strong buy, 21 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 196.16 USD.